Indivior | 销售和管理费用



Selling And Administration Expenses 更改 日
AstraZeneca USD 5.55B 307M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Glaxosmithkline GBP 2.7B 632M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Indivior 133M 11M 2024-09
J&J USD 5.11B 1.34B 2025-03
Kyowa Hakko Kirin JPY 40.38B 2.68B 2024-09
Merck USD 2.85B 148M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Sanofi EUR 1.24B 1.44B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Indivior 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.